Mr. Shipp joined Dow Chemical in 1981 and has held a number of leadership positions, including vice president and site director of Dow’s Louisiana operations and global operations director of the propylene oxide and glycols business. In his current role, Mr. Shipp oversees nine manufacturing sites.
“Mr. Shipp’s decades of leadership experience will add a valuable perspective to our Board,” said Michael H. Covert, CEO of CHI St. Luke’s Health in a statement. “His business acumen will be instrumental as we implement our strategic plan to advance the vision of our health system and build healthier communities throughout Southeast Texas.”
CHI St. Luke’s Health includes the Texas Heart Institute, eight hospitals, eight emergency centers, a Diagnostic & Treatment Center, a Radiation & CyberKnife Center and several locations for the St. Luke’s Medical Group.
More articles on executive moves:
9 latest hospital, health system CEO moves
After only 90 days, Plantation General Hospital CEO Robert Lee departs
Matt Schaefer to serve as Texas Children’s Hospital West Campus’ new president: 3 notes
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
